The Current Approach to the Hepatocellular Carcinoma; A Mini Review of Etiology, Prognosis and Treatment

Nuri Emrah Göret¹*, Ceren Canbey Göret², Mehmet Gokçeimam¹, Nalan Turan Güzel², Noyan İlhan¹ and Ömer Faruk Özkan³

Received:March 05, 2019;   Published: March 11, 2019

DOI: 10.32474/CTGH.2018.01.000130

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide and is one of the major causes of cancerrelated deaths. HCC is reported to be the second most fatal malignancy. The major risk factors for HCC are well known; the known risk factors include hepatitis C virus (HCV) and hepatitis B virus (HBV). Major advances have been reported in the treatment of HCC. Success of early diagnosis increases when these risk factors are identified, and the cases are followed up. It is reported that in the treatment of early-diagnosed HCC cases, ethanol injection or radiofrequency ablation methods as well as surgical resection should be preferred, particularly in cases without liver cirrhosis and in cases where the tumor is restricted. Similarly, liver transplantation may be an option for patients that meet specific criteria.

Keywords: Hepatocellular Carcinoma; Liver Carcinoma; Liver; Cirrhosis

Abstract| Introduction| References|